These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 1776410
1. Blood-retina barrier permeability in diabetes during acute ACE-inhibition. Engler CB, Parving HH, Mathiesen ER, Larsen M, Lund-Andersen H. Acta Ophthalmol (Copenh); 1991 Oct; 69(5):581-5. PubMed ID: 1776410 [Abstract] [Full Text] [Related]
2. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Parving HH, Larsen M, Hommel E, Lund-Andersen H. Diabetologia; 1989 Jul; 32(7):440-4. PubMed ID: 2680698 [Abstract] [Full Text] [Related]
3. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry. Schalnus R, Ohrloff C, Jungmann E, Maass K, Rinke S, Wagner A. Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099 [Abstract] [Full Text] [Related]
4. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study. Gardner TW, Eller AW, Friberg TR, D'Antonio JA, Hollis TM. Retina; 1995 Aug; 15(2):134-40. PubMed ID: 7624601 [Abstract] [Full Text] [Related]
5. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry. Schalnus R, Ohrloff C. Ophthalmic Res; 1995 Aug; 27 Suppl 1():116-23. PubMed ID: 8577448 [Abstract] [Full Text] [Related]
6. Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study. Engler C, Krogsaa B, Lund-Andersen H. Graefes Arch Clin Exp Ophthalmol; 1991 Aug; 229(5):442-6. PubMed ID: 1937077 [Abstract] [Full Text] [Related]
7. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy. Chahal P, Fallon TJ, Jennings SJ, Chowienczyk PJ, Kohner EM. Diabetes Care; 1986 Aug; 9(2):134-9. PubMed ID: 3698779 [Abstract] [Full Text] [Related]
8. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy. Larsen M, Hommel E, Parving HH, Lund-Andersen H. Graefes Arch Clin Exp Ophthalmol; 1990 Aug; 228(6):505-9. PubMed ID: 2265765 [Abstract] [Full Text] [Related]
9. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier. Engler CB, Sander B, Larsen M, Koefoed P, Parving HH, Lund-Andersen H. Acta Ophthalmol (Copenh); 1994 Dec; 72(6):663-7. PubMed ID: 7747571 [Abstract] [Full Text] [Related]
10. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. Moldow B, Sander B, Larsen M, Engler C, Li B, Rosenberg T, Lund-Andersen H. Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):881-9. PubMed ID: 9865617 [Abstract] [Full Text] [Related]
11. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous. Lobo CL, Bernardes RC, Santos FJ, Cunha-Vaz JG. Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960 [Abstract] [Full Text] [Related]
12. Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy. Cunha-Vaz JG, Mota CC, Leite EC, Abreu JR, Ruas MA. Arch Ophthalmol; 1985 Sep; 103(9):1307-11. PubMed ID: 2931063 [Abstract] [Full Text] [Related]
13. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects. Knudsen LL, Olsen T, Nielsen-Kudsk F. Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478 [Abstract] [Full Text] [Related]
14. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study. Ribeiro ML, Seres AI, Carneiro AM, Stur M, Zourdani A, Caillon P, Cunha-Vaz JG, DX-Retinopathy Study Group. Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797 [Abstract] [Full Text] [Related]
15. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Lobo CL, Bernardes RC, Figueira JP, de Abreu JR, Cunha-Vaz JG. Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598 [Abstract] [Full Text] [Related]
16. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Sander B, Larsen M, Moldow B, Lund-Andersen H. Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879 [Abstract] [Full Text] [Related]
17. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine. Nuzzi G, Venturini I, De Gregorio M, Arsenio L, Maraini G. Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399 [Abstract] [Full Text] [Related]
18. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy. Yoshida A, Kojima M, Ogasawara H, Ishiko S. Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365 [Abstract] [Full Text] [Related]
19. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels. Kernell A, Ludvigsson J, Finnström K. Acta Ophthalmol (Copenh); 1990 Aug; 68(4):415-20. PubMed ID: 2220357 [Abstract] [Full Text] [Related]
20. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide. Larsen M. Acta Ophthalmol Suppl (1985); 1993 Aug; (211):1-52. PubMed ID: 8318868 [Abstract] [Full Text] [Related] Page: [Next] [New Search]